G Glatting - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G Glatting

Showing results (21-30 of 45) with videos related to

Pageof 5

Sort By:

Radiology|March 12, 1998

Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findingsA Guhlmann, D Brecht-Krauss, G Suger, et al.

European Journal of Nuclear Medicine|April 24, 2001

Validation of myocardial blood flow estimation with nitrogen-13 ammonia PET by the argon inert gas technique in humansJ Kotzerke, G Glatting, J van den Hoff, et al.

Nuklearmedizin. Nuclear Medicine|May 20, 2006

Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.iG Glatting, T Kull, N M Blumstein, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 25, 2008

Biodistribution, cellular uptake and DNA-incorporation of the 2'-fluoro stabilized 5-iodo-2'-deoxyuridine analog 5-iodo-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil (FIAU)A Morgenroth, S Deisenhofer, M Neininger, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997

Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinomaS N Reske, K G Grillenberger, G Glatting, et al.

Neuroreport|September 28, 2000

In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic strokeA Gerhard, B Neumaier, E Elitok, et al.

Nuklearmedizin. Nuclear Medicine|October 17, 2007

Radiation dosimetry and biodistribution of the beta-amyloid plaque imaging tracer 11C-BTA-1 in humansS Thees, B Neumaier, G Glatting, et al.

Nuklearmedizin. Nuclear Medicine|December 1, 1993

[The noninvasive determination of resting myocardial blood flow in patients using 82 Rb in comparison with the argon method]S N Reske, M M Henrich, E Mate, et al.

Cancer Research|May 19, 2001

In vivo evaluation of 5-[(18)F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer modelU Seitz, M Wagner, A T Vogg, et al.

Pancreas|March 9, 2000